Home › Multiple Myeloma › New York › Queens
Multiple Myeloma clinical trials in Queens, NY
19 studies for Multiple Myeloma are looking for participants at sites in and around Queens (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
RecruitingPhase 3
- Long Island Jewish Medical Center, New Hyde Park · 9 mi away
- Northwell Health/ RJ Zuckerberg Cancer Center, Lake Success · 9 mi away
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
RecruitingPhase 3
- Northwell Health Cancer Institute, Lake Success · 9 mi away
- NYU Langone Hospital Long Island, Mineola · 11 mi away
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- NYU Winthrop, Mineola · 11 mi away
A Study of Dara-RVd and Teclistamab-RVd in People With Multiple Myeloma
RecruitingPhase 1/2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
RecruitingPhase 3
- MSK Nassau, Uniondale · 13 mi away
A Study of Teclistamab and Mezigdomide in People With Multiple Myeloma
RecruitingPhase 1
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
A Study of Voice as a Way to Monitor for Side Effects in People Receiving CAR T-Cell Therapy
RecruitingObservational study
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre · 10 mi away
Study of IgPro20 to Prevent Infection in People With Multiple Myeloma and Hypogammaglobulinemia
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi away
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Recruiting
- Memorial Sloan Kettering Nassau (All Protocol Activities), Uniondale · 13 mi away
A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
RecruitingPhase 3
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Hospital - Long Island, Mineola · 11 mi away
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Queens Cancer Center, Rego Park · 3 mi away
- Cohen Children's Medical Center, New Hyde Park · 9 mi away
- Northwell Health Monter Cancer Center, Lake Success · 9 mi away
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
RecruitingPhase 3
- MSK Nassau, Uniondale · 13 mi away
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
RecruitingPhase 3
- Research Site, New Hyde Park · 9 mi away
A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS)
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
A Study of Elranatamab and Cyclophosphamide in People With Multiple Myeloma
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
A Dietary Study for People With Multiple Myeloma
Recruiting
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
A Study of Talquetamab for People With Multiple Myeloma Who Have Received BCMA CAR T-Cell Therapy
RecruitingPhase 2
- Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale · 13 mi away
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
RecruitingObservational studyHealthy volunteers welcome
- Memorial Sloan Kettering Rockville, Rockville Centre · 10 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY59 studies
- Boston, MA45 studies
- Atlanta, GA42 studies
- Houston, TX39 studies
- Durham, NC36 studies
- Nashville, TN31 studies
- Denver, CO26 studies
- St. Louis, MO26 studies
- Rochester, MN25 studies
- Columbus, OH25 studies
- Chicago, IL24 studies
- Milwaukee, WI23 studies
Other studies in Queens
- Breast Cancer67 studies
- Non-Small Cell Lung Cancer49 studies
- Colorectal Cancer33 studies
- Ovarian Cancer30 studies
- Metastatic Cancer28 studies
- Prostate Cancer27 studies
- Endometrial Cancer26 studies
- Cancer (all types)25 studies
- Pancreatic Cancer23 studies
- Lung Cancer22 studies
- Acute Myeloid Leukemia19 studies
- Head and Neck Squamous Cell Carcinoma19 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.